Table 1.
Outcomes of the drug administrations.
| Control (N = 180) | Contextual intervention (N = 9) | |
|---|---|---|
| Drug cohort | ||
| Laxatives | 75 (41.7%) | 7 (77.8%) |
| Prokinetics | 105 (58.3%) | 2 (22.2%) |
| Baseline motility index | ||
| Mean (SD) | 3.91 (4.10) | 6.84 (4.30) |
| Median [Min, Max] | 3.02 [0, 13.3] | 6.34 [0, 12.5] |
| Clinical findings | ||
| Peristalsis | 60 (33.3%) | 2 (22.2%) |
| Bloated abdomen | 68 (37.8%) | 0 (0%) |
| Abdominal pain | 5 (2.8%) | 1 (11.1%) |
| Stools passed yet | 51 (28.3%) | 1 (11.1%) |
| Drugs | ||
| Bisacodyl oral (5 mg) | 7 (3.9%) | 0 (0%) |
| Bisacodyl rectal (5 mg) | 29 (16.1%) | 1 (11.1%) |
| Erythromycin i.v. (250 mg) | 57 (31.7%) | 0 (0%) |
| MCP i.v. (10 mg) | 14 (7.8%) | 2 (22.2%) |
| MCP + Neostigmine i.v. (10 mg + 0.5 mg) | 34 (18.9%) | 0 (0%) |
| MgSO4 oral (15 g) | 39 (21.7%) | 6 (66.7%) |
Clinical findings and measurements and drugs separated for the control and the contextual intervention group.